A groundbreaking review recently published in Genes & Diseases reveals the intricate link between human evolutionary history and the emergence of pathogenic variations in DNA damage repair (DDR) genes, fundamentally reshaping our understanding of cancer susceptibility in modern populations. This comprehensive analysis delves into how genetic shifts driven by evolutionary pressures have contributed to vulnerabilities that manifest as increased disease risk today, positioning DDR gene variants not as mere relics of distant ancestry but as dynamic elements shaped over millennia.
DNA damage repair genes form the cornerstone of genomic stability, orchestrating an elaborate network of pathways responsible for identifying and correcting a diverse range of DNA lesions. These lesions arise ubiquitously from both environmental insults—such as ultraviolet radiation and chemical exposure—and internal physiological processes like oxidative stress. The integrity maintained by DDR genes is essential for cellular homeostasis, preventing mutations that could otherwise propagate and culminate in malignancies. Understanding these genes’ multifaceted roles requires appreciating the variety of repair mechanisms, including base excision repair, nucleotide excision repair, homologous recombination, and mismatch repair, each tailored to specific types of DNA damage.
Notably, this review demonstrates that many pathogenic variations compromising DDR gene function have a relatively recent evolutionary origin, emerging predominantly within the timeline of modern human evolution rather than being conserved from ancestral species. Comparative genomic studies underscore the absence of these variants in closely related primates, indicating that they arose uniquely in Homo sapiens. This finding upends the traditional concept that deleterious mutations primarily descend from ancient lineages, highlighting instead the dynamic, ongoing evolution of the human genome.
The temporal distribution of these pathogenic DDR variants, as visualized through detailed timeline analyses, reveals a concentration within the last 10,000 years—a period coinciding with profound demographic shifts such as the advent of agriculture and the rise of complex societies. This temporal correlation suggests that significant changes in lifestyle, environmental exposures, and population genetics influenced the frequency and spread of these mutations. The review’s data emphasize a pronounced increase in variant carriers in more recent periods, hinting at evolutionary mechanisms that favored their persistence despite potential long-term health costs.
Intriguingly, the authors link the proliferation of pathogenic DDR variants with major historical events encompassing population expansions, migrations, and subsequent genetic admixture among diverse human groups. These demographic processes facilitated the dissemination of high-risk alleles beyond their regions of origin, contributing to their ubiquitous presence in contemporary global populations. Such admixture events exemplify how human movements and interactions have shaped the genetic landscape, entwining evolutionary advantages with deleterious consequences.
The review also explores the hypothesis that some of these variants may have been subject to positive or balancing evolutionary selection due to their roles beyond DNA repair, particularly in conferring advantageous traits related to immune function or developmental processes. For example, certain DDR gene variants may have enhanced pathogen resistance or modulated reproductive success, thereby being retained in populations despite increasing cancer susceptibility later in life. This evolutionary trade-off signifies the complex interplay between survival benefits in early life and disease vulnerabilities manifesting post-reproductive age.
From a molecular perspective, mutations in DDR genes can lead to a cascade of genomic instabilities, including chromosomal rearrangements and unchecked DNA replication errors, which are hallmark features in oncogenesis. The review systematically highlights how specific variant types—ranging from missense and nonsense mutations to large deletions—differentially impair repair pathways, influencing cancer type predisposition and severity. This nuanced understanding underscores the necessity of integrating evolutionary insights with molecular pathology to unravel cancer’s heterogeneous nature.
Moreover, the paper advocates for leveraging this evolutionary framework to inform future strategies in cancer prevention and therapy. By recognizing that susceptibility variants have evolved in response to selective pressures, researchers can better identify at-risk populations and tailor precision medicine approaches. For instance, screening programs might prioritize recently emerged variants with demonstrated pathogenicity, and therapeutic interventions could exploit DDR deficiencies to sensitize tumors to targeted treatments like PARP inhibitors.
In addition to cancer, the review acknowledges the broader implications of DDR gene evolution on other age-related diseases and genomic disorders. Genome stability is a universal requisite for cellular longevity, and defects in repair mechanisms can precipitate neurodegeneration, immunodeficiencies, and premature aging syndromes. Understanding the evolutionary trajectory of DDR genes, therefore, extends beyond oncology, offering insights into fundamental human health challenges.
The authors also highlight the importance of integrating paleogenomics and population genetics to reconstruct the selective landscapes that governed DDR gene variation emergence. Ancient DNA analyses reveal shared variants between prehistoric humans and modern populations, suggesting that environmental and cultural transitions—such as changes from hunter-gatherer to agricultural lifestyles—exerted pressures shaping these genes. This interdisciplinary approach exemplifies how evolutionary biology enriches the biomedical narrative.
Finally, the review articulates a call to action for the scientific community to consider evolutionary context as an essential factor in the study of human disease genetics. Pathogenic variations should not be viewed solely through a pathological lens but rather within the broader framework of human adaptation and survival. This paradigm shift holds the promise of uncovering novel therapeutic targets and refining our comprehension of the genotype-to-phenotype continuum.
In summary, this illuminating synthesis published in Genes & Diseases forges a vital connection between evolution and contemporary disease risk, portraying pathogenic DDR gene variations as integral elements shaped by our species’ biological journey. By decoding how human history has sculpted vulnerability to cancer, the work paves the way for evolutionary-informed medicine, offering hope for improved diagnostics, preventive measures, and therapeutic innovations tailored to the genetic realities of modern humans.
Subject of Research: Evolutionary origin of pathogenic variations in human DNA damage repair genes and their impact on cancer susceptibility
Article Title: Pathogenic variation in human DNA damage repair genes was originated from the evolutionary process of modern humans
News Publication Date: Not specified in the source text
Web References: https://www.sciencedirect.com/journal/genes-and-diseases; https://www.editorialmanager.com/gendis/default.aspx; https://x.com/GenesNDiseases
References:
Li J, Zhao B, Qin Z, et al. Pathogenic variation in human DNA damage repair genes was originated from the evolutionary process of modern humans. Genes & Diseases. 2026;13(3):101916. DOI:10.1016/j.gendis.2025.101916
Image Credits: GAD (Genes & Diseases)
